OTC:ADAPY | Operating Income | Adaptimmune Therapeutics PLC

Complete source-backed operating income history.

Available history
2014-06-30 to 2025-06-30
Data captured

Historical Operating Income

DateOperating Income
2025-06-30-$30.29M
2025-03-31-$45.73M
2024-12-31-$73.52M
2024-09-30-$14.68M
2024-06-30$68.7M
2024-03-31-$49.26M
2023-12-31-$49.86M
2023-09-30-$46.63M
2023-06-30-$44.91M
2023-03-31$1.66M
2022-12-31-$27.24M
2022-09-30-$42.99M
2022-06-30-$43.75M
2022-03-31-$49.98M
2021-12-31-$42.86M
2021-09-30-$42.18M
2021-06-30-$39.31M
2021-03-31-$37.89M
2020-12-31-$37.51M
2020-09-30-$35.88M
2020-06-30-$30.25M
2020-03-31-$29.76M
2019-12-31-$30.36M
2019-09-30-$40.12M
2019-06-30-$35.5M
2019-03-31-$33.79M
2018-12-31-$32.11M
2018-09-30$7.02M
2018-06-30-$28.88M
2018-03-31-$28.74M
2017-12-31-$29.7M
2017-09-30-$4.96M
2017-06-30-$23.78M
2017-03-31-$22.22M
2016-12-31-$14.66M
2016-09-30-$18.62M
2016-06-30-$22.7M
2016-03-31-$16.83M
2015-09-30-$8.31M
2015-06-30-$11.11M
2015-03-31-$5.61M

Annual Operating Income

DateOperating Income
2024-12-31-$68.76M
2023-12-31-$139.74M
2022-12-31-$163.97M
2021-12-31-$162.25M
2020-12-31-$133.41M
2019-12-31-$139.77M
2018-12-31-$82.37M
2017-12-31-$80.66M
2016-12-31-$72.8M
2015-06-30-$24.64M
2014-06-30-$11.52M